Skip to content
Menu

Wave Life Sciences, Inc. WVE

Full chart Compare
Set alert

Price alert · WVE

All alert types
2.56 USD -0.16 (-5.88%)

Regular-session close

2.56 0.00 0.00%

After hours · Nov 20, 4:25 PM ET

2.55 Day range 2.79
2.55 52-week range 21.73
YTD
-84.94%
1 year
-62.13%

Ownership

Held by insiders 15.50%
Held by institutions 85.60%
Float held by institutions 101.31%
Institutions 330

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Kennedy Capital Management, LLC0.00%429,1212.21MJun 29, 2026

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund2.09%4,111,30821.21MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF1.83%3,598,45118.57MJun 29, 2026
T. Rowe Price New Horizons Fund, Inc.1.16%2,287,10311.80MMar 30, 2026
T. Rowe Price Health Sciences Fund, Inc.1.07%2,107,23310.87MMar 30, 2026
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund0.84%1,659,8578.56MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund0.82%1,610,9618.31MMar 30, 2026

Included in Plus and up

Sign in to see Institutional ownership

How much funds own from their 13F filings, quarter by quarter, and the largest holders.

Free with an account

Sign in to see Insider activity

Two years of insider buying and selling by month, marked on the price.

Included in Plus and up

Sign in to see Congress trading

Every stock trade disclosed by members of the US Senate and House.

Free with an account

Sign in to see CEO compensation

What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.

Free with an account

Sign in to see Board of directors

Who sits on the board, who chairs it, and how long each director has served.

WVE insiders
InsiderRelationLatest transactionDateShares held
BOLNO PAUL B. M.D.Chief Executive OfficerSaleFeb 8, 2026275,520
CORRIGAN MARKDirectorSaleDec 7, 202528,815
FRANCIS CHRISTOPHER JOHNOfficerConversion of Exercise of derivative securityFeb 25, 202661,867
GSK PLCBeneficial Owner of more than 10% of a Class of SecurityPurchaseDec 10, 20250
MORAN KYLEChief Financial OfficerSaleFeb 8, 2026134,385
RA CAPITAL MANAGEMENT, L.P.Beneficial Owner of more than 10% of a Class of SecurityPurchaseMar 29, 20260